Clinical Trials Browser

Terminated × Carcinoma, Hepatocellular × fluoromisonidazole × Clear all

NCT03303469 2021-02-21

Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging

Phase 2 Terminated

3 enrolled 4 charts

Gastrointestinal

Carcinoma, Hepatocellular